Northwire Canada EditionMonday, July 13, 2026
Northwire
S 0.105 −32.3% OMI 0.310 −1.6% BMM 4.02 +5.8% CGD 0.630 +10.5% OCG 0.260 −7.1% CAMB 0.950 −5.0% HMR 0.600 −3.2% GOFL 0.025 +0.0% SIG 1.00 −2.9% SGQ 0.400 +33.3% AMCO 0.225 −10.0% TRS 0.055 +0.0% RRI 0.265 +0.0% GAL 0.395 −1.2% LIB 0.780 −14.3% SMY 0.290 +23.4% S 0.105 −32.3% OMI 0.310 −1.6% BMM 4.02 +5.8% CGD 0.630 +10.5% OCG 0.260 −7.1% CAMB 0.950 −5.0% HMR 0.600 −3.2% GOFL 0.025 +0.0% SIG 1.00 −2.9% SGQ 0.400 +33.3% AMCO 0.225 −10.0% TRS 0.055 +0.0% RRI 0.265 +0.0% GAL 0.395 −1.2% LIB 0.780 −14.3% SMY 0.290 +23.4%
Financings

PyroGenesis Announces Closing of Non-Brokered Private Placement

PYR · Price

Executive Summary

  • PyroGenesis Inc. closed its previously announced non‑brokered private placement, selling 3,654,537 units at $0.54 per unit for gross proceeds of $1,973,450.
  • The offering was oversubscribed; each unit consists of one common share and half of a common‑share purchase warrant (exercise price $0.70, exercisable for 36 months).
  • Net proceeds will be used for working capital and general corporate purposes; the placement is conditionally approved by the TSX pending final approval.

Key Details

  • Units sold: 3,654,537 (oversubscribed)
  • Price per unit: $0.54
  • Gross proceeds: $1,973,450
  • Original target: up to ~$1,000,000 via 1,851,852 units; actual raise nearly double the original target.
  • Unit composition: 1 common share + ½ common‑share purchase warrant (each whole warrant allows purchase of one common share at $0.70).
  • Warrant terms: exercisable for 36 months from closing; company may accelerate expiry if TSX price > $0.90 for 2 of any 5 consecutive trading days, with acceleration notice given within 15 days and expiry set 30 days after notice.
  • Statutory hold period: common shares and warrants subject to a four‑month‑plus‑one‑day hold from closing per securities legislation.
  • Insider participation: President & CEO P. Peter Pascali subscribed for ~ $400,000, the maximum allowed for insiders under regulations.
  • Use of proceeds: working capital and general corporate purposes.
  • Regulatory status: conditionally approved by TSX; final approval and customary closing conditions remain pending.

Notable Quotes

(No direct quotes were provided in the release.)

Read the original news release →

More from PYROGENESIS INC.